Loading company…
Milestone develops cell gene therapy services, primary cell platforms and related products.
Milestone focuses on clinical applications of stem cells and the isolation, culture and optimization of several cell types. Its offerings include cell separation services, drug development platforms and cell culture platforms, including liver cell isolation and in vitro drug efficacy evaluation. Founded in 2014, the company is based in Shanghai, China, with R&D and production centers in Beijing, Shenzhen and Zhejiang. In January 2025, it raised approximately CNY 100 million in Series A+ funding to develop primary cell models and related products and expand overseas.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in